Status
Completed
Phase
Not applicable
Enrollment
10
Locations
1
Results
Not posted
Publications
0
Study summary
The purpose of this study is to determine the efficacy and safety of two new patterns of controlled ovarian hyperstimulation (defined as total number of picked up eggs). This study will be performed in egg donors but these new patterns will be implemented in fertility preservation patients.
Interventions
PROCEDURE
We will administer in the tenth day of the cycle 0.25mg/day of ganirelix until the estradiol levels will be less than 60pgr/mL. Then, we'll start a standard protocol of controlled ovarian hyperstimulation beginning with 150 UI/day. At 6th day of stimulation we'll begin with the antagonist.
PROCEDURE
We will administer in the 20th day of the cycle 0.25mg/day of ganirelix until the estradiol levels will be less than 60pgr/mL. Then, we'll start a standard protocol of controlled ovarian hyperstimulation beginning with 150 UI/day. At 6th day of stimulation we'll begin with the antagonist.
Timeline
First posted
Jun 30, 2011
Study start
Mar 2010
Primary completion
Jun 2012
Study completion
Sep 2012
Results posted
Not reported
Registry updated
Sep 20, 2017
Outcomes
Number of eggs
Time frame · Participants will be followed after 1-3 hrs of follicular aspiration.
The results will be presented in one year, egg recipients will be followed until 12 weeks of pregnancy.
Not reported in the indexed record.
Eligibility
Inclusion Criteria: * premenopausal women 18-30 years old, with FSH levels \< 10mIU * irregular menstrual cycle * BMI between 12-28 * signed inform consent Exclusion Criteria: * Polycystic ovarian syndrome, gonadotropins allergy
Study locations
Spain. Showing up to 24 locations stored in the fast local snapshot.
Servei de Ginecologia i Obstetricia, Hospital del Mar-Parc Salut Mar
Barcelona, Spain
Publications
No PMID-linked publications were present in this registry snapshot.
Related trials
Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita) · Infertility, Female · Ovulation Induction
Early Phase 1
Not yet recruiting
189
2026-07
University of Delaware · Estrogen · Premenopause
Phase 4
Recruiting
30
2026-07
ART Fertility Clinics LLC · Healthy
Not applicable
Not yet recruiting
20
2026-05
Fundación Santiago Dexeus Font · Infertility
Phase 4
Completed
110
2026-04
Instituto Bernabeu · IVF
Phase 4
Completed
150
2026-03
Hanoi Medical University · Infertility (IVF Patients) · Embryo Morphokinetics
Not applicable
Recruiting
148
2026-02
University Hospital, Ghent · Ovarian Stimulation · Quality of Life
Phase 4
Recruiting
60
2025-12
Tam Anh TP. Ho Chi Minh General Hospital · Diminished Ovarian Reserve
Not applicable
Recruiting
730
2025-12
Related PeptideStat pages
Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.